Tominari, Shunsuke
Yasuda, Megumi
Kato, Takehiro http://orcid.org/0000-0003-3236-2463
Sakai, Mayu
Kubota, Sodai
Nonomura, Kenta
Hirose, Tokuyuki
Takao, Ken
Liu, Yanyan
Mizuno, Masami
Hirota, Takuo
Iizuka, Katsumi
Suwa, Tetsuya
Horikawa, Yukio
Yabe, Daisuke
Article History
Received: 22 December 2020
Accepted: 22 April 2021
First Online: 5 May 2021
Declarations
:
: Author YH received a lecture fees from Kowa and MSD. Author DY received a research grant from TERUMO CORPORATION, lecture fees from Novo Nordisk Pharma, Nippon Boehringer Ingelheim and MSD, donations from Nippon Boehringer Ingelheim and endowed departments by commercial entities from ONO PHARMACEUTICAL CO LTD, Taisho Pharma CO Ltd, ARKRAY, Inc, Takeda Pharmaceutical Company Limited, Nippon Boehringer Ingelheim and Novo Nordisk Pharma. Author ST, MY, TK, MS, SK, YL, KN, TH, MM, TH, KI and TS declare that they have no conflict of interest. The authors declare that they have no competing interests relevant to this study.
: Formal ethics approval was waived for this paper by the ethics committee of Gifu University Graduate School of Medicine due to its being a case report.
: Written informed consent was obtained from the family for publication of this report; the patient died after her transfer to a long-term care bed hospital.